Article: Use of intradermal botulinum toxin to reduce sebum production and facial pore size.(ORIGINAL ARTICLES)(Report)

Article: Patent No. 7,615,230 Issued on Nov. 10, Assigned to Graceway ...
US Fed News Service, Including US State News;  November 11, 2009 ;     415 words ... ... Catherine R. Kostlan of Saline, Mich., and Kimberly Wade of Brighton, Mich., have developed a method for decreasing sebum production. The inventors were issued U.S. Patent No. 7,615,230 on Nov. 10. The patent has been assigned to Graceway Pharmaceuticals ...

Article: S Black has produced REGU[TM]-SEB, a new formulation designed to ...
Cosmetics International;  July 10, 2002 ;     554 words ...S Black has produced REGU[TM]-SEB, a new formulation designed to control and reduce sebum production in skin that is prone to oiliness. The ingredient, which is manufactured by Pentapharm Limited, contains polyphenol-rich fractions ...

Article: Botulinum toxin popularity surges; non-cosmetic ...
Dermatology Times;  October 1, 2005 ;     700+ words ... ... Chicago - The popularity of botulinum toxin type A injections for correcting ... considered: The number of botulinum toxin type A procedures rose 157 ... procedures involving the use of botulinum toxin will become more ubiquitous ...

Article: Botulinum toxin type B starts strong as alternative
Dermatology Times;  November 1, 2001 ;     700+ words ... ... if Myobloc continues to match success of botulinum toxin A Dallas - Botulinum toxin type B (Myobloc) is an alternative modality ... and the longevity of its action. "Like botulinum toxin type A,botulinum toxin type B appears ...

Article: Botulinum toxin indications continue to grow
Dermatology Times;  July 1, 2000 ;     700+ words ... ... surgeons continue to find new uses for botulinum toxin A (Botox) injection, but careful ... Dermatology. He described use of botulinum toxin at various sites for fine-tuning ... various indications to be discussed, botulinum toxin treatment cannot be approached in ...

Article: Botulinum toxin gains popularity for variety of ...
Ophthalmology Times;  September 15, 2006 ;     700+ words ... ... reimbursement coding.doc The use of botulinum toxin by ophthalmologists to treat a variety ... currently available formulations of botulinum toxin are serotype A (Botox, Allergan ... Myobloc, Elan Pharmaceuticals). Botulinum toxin A is the serotype used far more frequently ...

Article: Botulinum toxin provides many cosmetic, functional ...
Ophthalmology Times;  July 1, 2005 ;     700+ words ... ... ophthalmologists who understand the mechanism of botulinum toxin type A (Botox, Allergan) and the ... many functional and cosmetic uses for botulinum toxin in their practices, said Julian D ... have been pioneers in the field of botulinum toxin use. I think we need to continue ...